Key result
Dendritic cells transfected with HVEM-expressing adenovirus protected against experimental autoimmune myocarditis by inducing IL-10-producing CD4+ T cells, whereas HVEM-Ig had no protective effect.
Why the study?
Does HVEM-overexpressing dendritic cell therapy protect against experimental autoimmune myocarditis?
Does HVEM-overexpressing dendritic cell therapy protect against experimental autoimmune myocarditis?
HVEM-overexpressing dendritic cells protect against experimental autoimmune myocarditis by inducing IL-10-producing CD4+ T cells, suggesting a potential gene therapy approach for myocarditis.
Answers are grounded in this paper and cite their sources.
Animal data do not support clinical use of HVEM-DC therapy; leaves open translation to human autoimmune myocarditis.
AIMS: Herpes virus entry mediator (HVEM) is considered to be a molecular 'switch' for immune responses, and a role in immune modification has been reported. The aim of this study was to assess whether HVEM-mediated immune suppression could protect against experimental autoimmune myocarditis (EAM) induced by myosin. METHODS AND RESULTS: We constructed HVEM-expressing adenovirus (AdHVEM) and fusion protein HVEM-Ig and evaluated their roles in immunoregulation in vitro and in vivo. Immunoregulation of dendritic cells (DCs) infected with recombinant virus or treated with HVEM-Ig was then studied. DCs transfected with AdHVEM (DC-AdHVEM) were protected against EAM, whereas HVEM-Ig had no protective effect. Further study showed that DC-AdHVEMs produced a regulatory cytokine, IL-10, which had further effects on induction of IL-10 producing CD4(+) T cells. This subset of T cells was then responsible for the protection against EAM. CONCLUSION: Myosin-DC-AdHVEM cell gene therapy appears to be a safe and effective way of inhibiting the development of EAM. The signal induced by HVEM seems to play different roles in different cells.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2009) studied Experimental autoimmune myocarditis (EAM). HVEM-expressing adenovirus (AdHVEM) transfected dendritic cells vs. HVEM-Ig was evaluated on Protection against experimental autoimmune myocarditis. Dendritic cells transfected with HVEM-expressing adenovirus protected against experimental autoimmune myocarditis by inducing IL-10-producing CD4+ T cells, whereas HVEM-Ig had no protective effect.
Synapse has enriched 10 related papers. Consider them for comparative context: